Literature DB >> 27350313

National Bloodstream Infection Surveillance in Switzerland 2008-2014: Different Patterns and Trends for University and Community Hospitals.

Niccolò Buetti1, Jonas Marschall1, Andrew Atkinson1, Andreas Kronenberg1.   

Abstract

OBJECTIVE To characterize the epidemiology of bloodstream infections in Switzerland, comparing selected pathogens in community and university hospitals. DESIGN Observational, retrospective, multicenter laboratory surveillance study. METHODS Data on bloodstream infections from 2008 through 2014 were obtained from the Swiss infection surveillance system, which is part of the Swiss Centre for Antibiotic Resistance (ANRESIS). We compared pathogen prevalences across 26 acute care hospitals. A subanalysis for community-acquired and hospital-acquired bloodstream infections in community and university hospitals was performed. RESULTS A total of 42,802 bloodstream infection episodes were analyzed. The most common etiologies were Escherichia coli (28.3%), Staphylococcus aureus (12.4%), and polymicrobial bloodstream infections (11.4%). The proportion of E. coli increased from 27.5% in 2008 to 29.6% in 2014 (P = .04). E. coli and S. aureus were more commonly reported in community than university hospitals (34.3% vs 22.7%, P<.001 and 13.9% vs 11.1%, P<.001, respectively). Fifty percent of episodes were community-acquired, with E. coli again being more common in community hospitals (41.0% vs 32.4%, P<.001). The proportion of E. coli in community-acquired bloodstream infections increased in community hospitals only. Community-acquired polymicrobial infections (9.9% vs 5.6%, P<.001) and community-acquired coagulase-negative staphylococci (6.7% vs 3.4%, P<0.001) were more prevalent in university hospitals. CONCLUSIONS The role of E. coli as predominant pathogen in bloodstream infections has become more pronounced. There are distinct patterns in community and university hospitals, potentially influencing empirical antibiotic treatment. Infect Control Hosp Epidemiol 2016;37:1060-1067.

Entities:  

Mesh:

Year:  2016        PMID: 27350313     DOI: 10.1017/ice.2016.137

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  10 in total

1.  Rapid diagnosis of sepsis with TaqMan-Based multiplex real-time PCR.

Authors:  Chang-Feng Liu; Xin-Ping Shi; Yun Chen; Ye Jin; Bing Zhang
Journal:  J Clin Lab Anal       Date:  2017-05-17       Impact factor: 2.352

Review 2.  Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Use with Positive Blood Cultures: Methodology, Performance, and Optimization.

Authors:  Matthew L Faron; Blake W Buchan; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2017-08-30       Impact factor: 5.948

3.  Antimicrobial resistance in bacterial pathogens among hospitalised patients with severe invasive infections.

Authors:  Ovidiu Zlatian; Andrei Theodor Balasoiu; Maria Balasoiu; Oana Cristea; Anca Oana Docea; Radu Mitrut; Demetrios A Spandidos; Aristides M Tsatsakis; Gabriela Bancescu; Daniela Calina
Journal:  Exp Ther Med       Date:  2018-09-14       Impact factor: 2.447

4.  Shifting trends and age distribution of ESKAPEEc resistance in bloodstream infection, Southwest China, 2012-2017.

Authors:  Shuangshuang Yang; Haofeng Xu; Jide Sun; Shan Sun
Journal:  Antimicrob Resist Infect Control       Date:  2019-03-29       Impact factor: 4.887

5.  The Epidemiology of Bloodstream Infections and Antimicrobial Susceptibility Patterns: A Nine-Year Retrospective Study at St. Dominic Hospital, Akwatia, Ghana.

Authors:  John Gameli Deku; Mavis Puopelle Dakorah; Sylvester Yao Lokpo; Verner N Orish; Francis Abeku Ussher; Godsway Edem Kpene; Vida Angmorkie Eshun; Eunice Agyei; Waldermer Attivor; James Osei-Yeboah
Journal:  J Trop Med       Date:  2019-09-19

6.  Development and validation of a risk score for predicting positivity of blood cultures and mortality in patients with bacteremia and fungemia.

Authors:  Felipe Francisco Tuon; João Paulo Telles; Juliette Cieslinski; Marilia Burdini Borghi; Raquel Zanella Bertoldo; Victoria Stadler Tasca Ribeiro
Journal:  Braz J Microbiol       Date:  2021-07-21       Impact factor: 2.214

7.  Increasing proportion of vancomycin-resistance among enterococcal bacteraemias in Switzerland: a 6-year nation-wide surveillance, 2013 to 2018.

Authors:  Vanja Piezzi; Michael Gasser; Andrew Atkinson; Andreas Kronenberg; Danielle Vuichard-Gysin; Stephan Harbarth; Jonas Marschall; Niccolò Buetti
Journal:  Euro Surveill       Date:  2020-09

8.  Impact of Location of Acquisition of Gram-Positive Bloodstream Infections on Clinical Outcomes Among Patients Admitted to Community Hospitals.

Authors:  Julia A Messina; Rebekah W Moehring; Kenneth E Schmader; Deverick J Anderson
Journal:  Infect Drug Resist       Date:  2020-08-25       Impact factor: 4.003

9.  A retrospective study on Escherichia coli bacteremia in immunocompromised patients: Microbiological features, clinical characteristics, and risk factors for shock and death.

Authors:  Xiaoyan Tao; Haichen Wang; Changhang Min; Ting Yu; Yi Luo; Jun Li; Yongmei Hu; Qun Yan; Wen' En Liu; Mingxiang Zou
Journal:  J Clin Lab Anal       Date:  2020-04-08       Impact factor: 2.352

10.  Rapid molecular detection of pathogenic microorganisms and antimicrobial resistance markers in blood cultures: evaluation and utility of the next-generation FilmArray Blood Culture Identification 2 panel.

Authors:  Tanja Holma; Jukka Torvikoski; Nathalie Friberg; Annika Nevalainen; Eveliina Tarkka; Jenni Antikainen; Jari J Martelin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-08-05       Impact factor: 3.267

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.